Clinical Trial Update: Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

View source ↗

Summary

The document announces the recruitment status for a clinical evaluation of BCDx to monitor recurrence in non-muscle invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• BCDx (BCDx)

Snippet

Sponsor: Early is Good Inc. | Conditions: Bladder Cancer | Status: RECRUITING